APB A101
Alternative Names: APB-A101Latest Information Update: 22 Jan 2023
At a glance
- Originator APITBIO
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Hepatitis B surface antigen presurface protein 1 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatitis B
Most Recent Events
- 07 Dec 2022 Early research in Hepatitis B in South Korea (Parenteral) (APITBIO pipeline, December 2022)